Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Curr Opin Immunol. 2014 Mar 27;0:90–96. doi: 10.1016/j.coi.2014.02.010

CLONAL AND CELLULAR DYNAMICS IN GERMINAL CENTERS

Gabriel D Victora 1,*, Luka Mesin 1
PMCID: PMC4037377  NIHMSID: NIHMS572441  PMID: 24681449

Abstract

Germinal centers (GCs) are the site of antibody affinity maturation, a process that involves complex clonal and cellular dynamics. Selection of B cells bearing higher-affinity immunoglobulins proceeds via a stereotyped pattern where B cells migrate cyclically between the GC’s two anatomical compartments. This process occurs in a timeframe that is well suited to analysis by intravital microscopy, and much has been learned in recent years by use of these techniques. On a longer time scale, the diversity of B cell clones and variants within individual GCs is also thought to change as affinity maturation progresses; however, our understanding of clonal dynamics in individual GCs is limited. We discuss recent progress in the elucidation of clonal and cellular dynamics patterns.

Introduction

The high-affinity antibodies typical of a secondary immune response emerge from their lower-affinity precursors through a process of random mutation and targeted selection known as affinity maturation. This process takes place in specialized structures—germinal centers (GCs)—that form within the B cell follicles of secondary lymphoid organs upon infection or immunization [1-5]. While in these structures, B cells undergo somatic hypermutation (SHM) of their immunoglobulin (Ig) genes, triggered by the enzyme activation-induced cytidine deaminase (AID)[6]. A minority of B cells with affinity-enhancing mutations are then selected based on the increased ability of their antigen-binding B cell receptors (BCRs) to retrieve antigen from the surface of follicular dendritic cells (FDCs) and present it to a limiting number of GC-resident T follicular helper (Tfh) cells [4,7].

GCs are divided into two anatomically distinct compartments—a dark zone (DZ) and a light zone (LZ). A major feature of the GC reaction is the close association between affinity-based selection and B cell migration between these compartments: upon positive selection in the LZ, GC B cells transit to the DZ, where they proliferate and mutate their Ig genes, subsequently returning to the LZ to test their mutated Igs against antigen retained on FDCs. In recent years, the emergence of multiphoton microscopy has dramatically increased our ability to observe this migratory process in real time, providing invaluable insight into the mechanics of GC selection [7-11]. These and other studies have been reviewed extensively elsewhere [3,4,12]. In the present review, we discuss specific points regarding the interplay of clonal and cellular dynamics in the GC that in our view remain incompletely understood.

Clonality in the early GC

Before the LZ and DZ form, and thus before intraclonal GC selection can begin, GCs must develop by expansion of precursors selected from within a large pool of naïve B cells that compete interclonally (Fig. 1). Early studies of GC clonality using allelically marked mixtures of B cells or immunization with two distinct antigens estimated that B cells within mature GCs are the progeny of as few as 1-3 precursor clones [13,14]. Because cells in mature GCs have presumably gone through several cycles of purifying selection, these early studies were in fact reporting on the number of surviving clones rather than of founder clones [15]. Later studies showed that clonal diversity in early GCs can be substantially higher than in mature GCs, suggesting that GCs may initially grow by accretion of many B cell clones that are subsequently filtered by selection to yield the 1-3 clones of mature GCs [16]. Studies in which Ig gene rearrangements were amplified from single cells picked from individual human GCs also support a more complex pattern of GC clonality [15]. Access of B cell clones to the early GC is controlled by a balance between a low B cell-intrinsic activation threshold [17-20] and interclonal competition for T cell signals that regulate B cell entry into the GC [20], possibly by triggering the downregulation of the G-coupled receptor Ebi2 [21,22]. For example, B cells with very low affinity for nitrophenol haptens, which are largely excluded from GCs when transferred into wild-type mice, form normal GCs when in the absence of competition from other B cell clones [18-20]. Interclonal competition is also likely to constrict the breadth of antibody specificities that are allowed entry into the GC. Knowledge of how to manipulate this early selective step may therefore improve our ability to generate antibody responses to non-immunodominant epitopes.

Figure 1.

Figure 1

Potential model for clonal dynamics during germinal center formation. GCs are seeded by a small fraction of the large repertoire of naïve B cells potentially responsive to the immunizing antigen by pre-GC competition for T cell help (Bottleneck #1), generating GCs composed of a limited number of clones. These GCs are then further purged from less competitive clones by a second round of competition for T cell help in the mature GC (Bottleneck #2), yielding the 1-3 clones observed in experiment.

As the GC reaction proceeds, B cell selection shifts from interclonal competition to a system increasingly dominated by competition among variants of a single clone generated by SHM [16]. This progressive “monoclonalization” is limited by the segregation of individual GCs from the B cell perspective, which allows several different clonal trees to evolve simultaneously in different GCs. A further contributing factor may be the invasion of ongoing GCs by newly activated B cells with a competitive advantage in antigen binding or access to T cells [9,23]. The need for competitive advantage limits invasion to special circumstances, such as when T-cell help specific for the incoming B cells is available [23]. Thus, GC invasion and reutilization may be confined to sites prone to constant antigenic stimulation, such as mucosal associated lymphoid tissue. Accordingly, following oral immunization, circulating B cells repeatedly re-enter antigen-experienced GCs, as revealed by the clonal relationship between GC B cells derived from multiple Peyer’s Patches [24].

Dynamics of selection in the mature GC

Within mature GCs, selection and cell division are polarized towards LZ and DZ, respectively, although the extent of cell division in the LZ may vary slightly depending on the model employed [7,8,25,26]. Polarization of GCs into these two compartments relies on gradients of the chemokines CXCL13 and CXCL12, whose receptors—CXCR5 and CXCR4—are upregulated in LZ and DZ B cells, respectively [7,27]. Early attempts at mathematical modeling of the GC reaction concluded that efficient affinity maturation could only be attained if cells were allowed to cycle functionally between periods of proliferation and selection, and, by extension, to cycle physically between DZ and LZ [28,29]. These predictions led to a model for affinity maturation known as cyclic re-entry, which would be confirmed experimentally only after the introduction of intravital microscopy to the field a decade later [7-10].

The close association between interzonal migration and affinity maturation has raised interest in the mechanisms that trigger the transition of GC B cells from one zone to another (Fig. 2). Because LZ to DZ migration is equivalent to positive selection [7], most of the emphasis has been placed on the cellular and molecular mechanisms driving this transition. It was predicted mathematically [30,31] that LZ to DZ migration is restricted by the ability of a GC B cell to recruit help from a limiting number of GC-resident Tfh cells, which is in turn determined by the ability of the B cell to retrieve and present antigen deposited on FDCs. To directly test this hypothesis, we developed a system in which the density of cognate peptide on a small subset of GC B cells expressing the surface lectin DEC205 could be artificially increased by injection of the T cell antigen fused to a monoclonal antibody to this protein. DEC205-expressing B cells thus targeted followed the predicted steps of selection, migrating in mass from LZ to DZ and then proliferating vigorously within the GC or differentiating into plasmablasts [7]. Importantly, the larger fraction of untargeted (DEC205−/−) GC B cells almost entirely disappeared from GCs 48-72h following treatment, leading to the conclusion that Tfh are the limiting factor in GC selection [7].

Figure 2.

Figure 2

Interplay of dynamics and selection in the germinal center reaction. B cells activated by antigen migrate to the T zone–follicle (TB) border, where they compete for a limiting number of helper T cells. Selected B cells migrate to the center of the follicle, where they proliferate extensively, giving origin to mature GCs. In these structures, GC B cells cycle between periods of proliferation and AID-driven mutation in the dark zone (DZ) and antigen-driven selection in the light zone (LZ). LZ-DZ cycling, selection for cyclic re-entry, and exit from the GC as memory (BMEM) or plasma cells (PC) are likely to be controlled by interaction with a limiting number of T follicular helper (Tfh) cells. Changes in expression of selected G-protein coupled receptors required for the various steps in B cell migration are indicated in red. Cell phenotypes and cell-cycle stages are indicated in blue.

In such a model, the primary function of the BCR would be that of an endocytic receptor, and the role of signaling downstream of the BCR would be limited to tasks other than executing the selection of higher affinity clones and variants. Indeed, when cognate peptide levels are equalized among all GC B cells by anti-DEC205 targeting, affinity maturation ceases to operate despite the variation in BCR affinity among GC B cells [7]. The notion that BCR signaling plays a limited role in selection is further supported by work by Shlomchik and colleagues showing that phosphorylation of proximal components of the BCR signaling pathway is surprisingly absent from IgM+ GC B cells (with the notable exception of a brief spike during the G2/M transition of the cell cycle) [32]. This absence is potentially due to high activity of SH2-containing phosphatases, which is supported by the finding of residual BCR-proximal phosphorylation in mice bearing a natural low-expressing variant of the FcγRIIb promoter [33]. These findings suggest that affinity-based selection—which presumably corresponds to the G1-S transition of the cell cycle—can proceed in the absence of overt BCR signaling. Whether this lack of downstream activity is also the case for isotypes other than IgM is at present not clear. Whereas little work has been done on IgG signaling in GCs, a series of recent studies suggest that the IgE BCR may have unique signaling properties in GC cells [34-36] [Reference to C. Allen’s review in this series]. Thus, although affinity maturation requires affinity-dependent retrieval of antigen from FDC and presentation to Tfh, signaling downstream of the BCR appears to play a secondary role in defining which B cells will be positively selected, and may be more important in guiding post-GC differentiation or in the culling of autoreactive clones [37-40].

Much less is known about how GC B cells are driven to return from DZ to LZ. Forcing interactions between GC B and T cells by targeting antigen to DEC205 induces a protracted period of residency of GC B cells in the DZ (24-48 hours, compared to the ~4 hour half-life under non-manipulated conditions). Mathematical modeling indicates that B cells must undergo at least 5-6 cell divisions while remaining in the DZ if the DZ/LZ B cell ratios obtained in experiment are to be achieved [41]. This suggests that the strength of the signal provided to B cells by Tfh cells determines the number of divisions (and the length of time) that a B cell will subsequently undergo (spend) in the DZ. Because the phenotype of LZ cells is dominated by a strong signature of NF-κB activation [7,25], we hypothesized that, once a B cell exits this proliferative phase, it would be free to migrate back to the LZ, where it would upregulate the LZ signature genes as a result of contact with activating signals from antigen and T cells [25]. However, subsequent work by Cyster and colleagues using mice with CXCR4-deficient B cells showed that physical location in the LZ alone is insufficient to drive the LZ phenotype [26]. This suggests that B cells have an intrinsic “timer” that determines the switch in phenotype from DZ to LZ, either by directly triggering the LZ gene expression program, or by rendering B cells susceptible to activating signals present in the LZ. A model therefore emerges in which Tfh cells in the LZ extrinsically trigger selected B cells to migrate to the DZ. B cells then enter a proliferative state, in which they divide one or more times. Release from this state, return to the LZ, and acquisition of a LZ phenotype (or of the the ability to respond to activation signals in the LZ) are temporally controlled in a B cell-intrinsic manner.

A common theme across these studies is that they place positive selection by Tfh cells in control of both LZ to DZ and DZ to LZ migration. Whereas the former occurs by triggering B cells to enter cell cycle and migrate to the DZ, the latter is achieved by setting the B cell DZ timer in accordance with the strength of the T-B interaction (Fig. 2). The notion of a GC reaction controlled by access to T cell help has important functional implications. A system in which selection is dependent on two consecutive steps—affinity-dependent retrieval of antigen from FDCs followed by cognate engagement of helper T cells—is likely to be more noisy (i.e., not all selected cells are higher-affinity, and vice-versa) than one in which B cells are selected based on direct binding to antigen. This may explain why selection proceeds at a slower rate than expected [30], or why heterogeneity of affinities in serum increases rather than decreases as a function of time [42]. While theoretically distracting the system from achieving the highest affinity in the shortest amount of time, such built-in noise is likely to be advantageous in most real-life scenarios, where a diversity of antibodies is required [43].

Less is known about what triggers the differentiation of GC B cells into post-GC plasma cells and memory B cells. We have reviewed the evidence for the role of Tfh cells and other signals in a previous article [4].

Tfh cell dynamics

Whereas the dynamics of B cells in the GC are known to some detail, those of Tfh cells have only begun to be elucidated [44]. After an initial period of interaction with B cells at the follicle border [45-47], CD4 T cells invade the B cell zone, initially dispersing throughout the follicle and only gradually accumulating within GCs [45,48]. Entry into the follicle and GC is dependent, among other factors, on expression of CXCR5, SAP, and Bcl6 in the Tfh cells themselves, and of ICOSL on naïve follicular B cells [49-52]. However, not all T cells expressing CXCR5 are located inside GCs, and neither do all T cells physically within GCs express CXCR5 [48]. Together with data showing that CXCR5 deficiency only partially impairs the formation of GCs and T cell homing to these structures [53], the lack of specificity of CXCR5 as a marker suggests that additional cues must exist that control Tfh residency in the GC.

In contrast to B cells, GC Tfh cells are highly polyclonal within a given GC, and the same clones can be found across many different GCs at approximately equal ratios [48,54-56]. Equal distribution among different GCs can be explained both by the absence of an overt founder effect and by continuous exchange of Tfh cells between mature GCs [48]. Furthermore, newly activated T helper cell clones can invade ongoing GCs and provide help to cognate B cells within these GCs [48]. At present, one can only speculate on why GCs should be open to free exchange of Tfh cells while B cell exchange is limited. As noted above, being self-contained from the perspective of B cells allows GCs to evolve different responses in parallel, preventing a single B cell clone from dominating the GC response. On the other hand, free exchange of Tfh cells between GCs and engagement of newly activated Tfh clones may ensure that B cell evolution is supported by a broad assortment of T cells, which may contribute to the robustness of the system, for instance in face of frequently mutating T cell epitopes (Fig. 3).

Figure 3.

Figure 3

Tfh dynamics in germinal centers. From the B cell perspective, GCs are thought to be “islands” dominated by one or a few clones that differ between neighboring GCs. In contrast, Tfh cells freely exchange between GCs, and Tfh clones are distributed in approximately equal proportions among GCs from the same LN. Additionally, newly activated T cells (light green) can join and contribute to ongoing GC reactions.

Clinical Implications

Most vaccines currently licensed for human use are thought to work by eliciting neutralizing antibodies [57]. Recently, the ability to induce broadly neutralizing antibodies (bnAbs) against HIV and influenza by vaccination has emerged as an important and potentially achievable goal [58,59], highlighting the importance of understanding the GC reaction in detail. In this context, a crucial question is how breadth and neutralization can evolve within a reaction that selects variants solely on the basis of affinity/avidity. A recently published study of the co-evolution of virus and bnAbs within a single patient and from the very onset of infection provides some insight in this sense [60]. BnAbs in this patient appeared to have evolved during a period when many variants of the virus were present simultaneously. One possible explanation for this finding is that, in such a scenario, GC B cells with greater breadth would also have higher avidity because of their ability to bind multiple viral variants on the surface of FDCs, which could lead to their preferential selection over B cells with similar or even higher affinity but more narrow breadth. A second important observation is that the most potent bnAbs against HIV carry an inordinately large number of somatic mutations (up to 30% of amino acids), which appear to be functionally required for broad neutralization [61-63]. Such high mutational load is almost an order of magnitude higher than what is currently attainable, for example, by influenza vaccination [64]. How such antibodies evolve during infection and whether they can be induced by vaccination are open questions in the GC field.

Conclusion

Recent years have witnessed a leap in our understanding of GC dynamics, driven to a large extent by the advent of intravital microscopy. Nevertheless, important gaps remain in our knowledge of how B cells are selected to enter, thrive in, and exit the GC. Filling in these gaps will undoubtedly contribute to future efforts to design more effective vaccines against challenging pathogens.

Highlights.

  • Germinal center clonal diversity is kept low by multiple bottlenecks

  • Germinal center selection is inextricably linked to cellular dynamics

  • T cell help regulates multiple aspects of germinal center B cell dynamics

  • Better understanding of germinal center dynamics will aid vaccine development

Acknowledgements

We thank H. Eisen and M. Carroll for critical review of our manuscript. G.V. is supported by NIH grant DP5OD012146 and by the March of Dimes Foundation Basil O’Connor Award.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  • 1.MacLennan IC. Germinal centers. Annu Rev Immunol. 1994;12:117–139. doi: 10.1146/annurev.iy.12.040194.001001. [DOI] [PubMed] [Google Scholar]
  • 2.Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381:751–758. doi: 10.1038/381751a0. [DOI] [PubMed] [Google Scholar]
  • 3.Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity. 2007;27:190–202. doi: 10.1016/j.immuni.2007.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Victora GD, Nussenzweig MC. Germinal centers. Annual review of immunology. 2012;30:429–457. doi: 10.1146/annurev-immunol-020711-075032. [DOI] [PubMed] [Google Scholar]
  • 5.Nieuwenhuis P, Opstelten D. Functional anatomy of germinal centers. Am J Anat. 1984;170:421–435. doi: 10.1002/aja.1001700315. [DOI] [PubMed] [Google Scholar]
  • 6.Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol. 2002;20:165–196. doi: 10.1146/annurev.immunol.20.090501.112049. [DOI] [PubMed] [Google Scholar]
  • 7**.Victora GD, Schwickert TA, Fooksman DR, Kamphorst AO, Meyer-Hermann M, Dustin ML, Nussenzweig MC. Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter. Cell. 2010;143:592–605. doi: 10.1016/j.cell.2010.10.032. This study identifies the phenotypes and transcriptional programs of light and dark zone GC cells, quantifies interzonal migration rates, and shows that T cell help is the limiting factor in GC selection.
  • 8*.Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science. 2007;315:528–531. doi: 10.1126/science.1136736. One of three pioneer studies using intravital imaging to study the germinal center reaction
  • 9*.Schwickert TA, Lindquist RL, Shakhar G, Livshits G, Skokos D, Kosco-Vilbois MH, Dustin ML, Nussenzweig MC. In vivo imaging of germinal centres reveals a dynamic open structure. Nature. 2007;446:83–87. doi: 10.1038/nature05573. One of three pioneer studies using intravital imaging to study the germinal center reaction
  • 10*.Hauser AE, Junt T, Mempel TR, Sneddon MW, Kleinstein SH, Henrickson SE, von Andrian UH, Shlomchik MJ, Haberman AM. Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity. 2007;26:655–667. doi: 10.1016/j.immuni.2007.04.008. One of three pioneer studies using intravital imaging to study the germinal center reaction
  • 11.Fooksman DR, Schwickert TA, Victora GD, Dustin ML, Nussenzweig MC, Skokos D. Development and migration of plasma cells in the mouse lymph node. Immunity. 2010;33:118–127. doi: 10.1016/j.immuni.2010.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hauser AE, Shlomchik MJ, Haberman AM. In vivo imaging studies shed light on germinal-centre development. Nat Rev Immunol. 2007;7:499–504. doi: 10.1038/nri2120. [DOI] [PubMed] [Google Scholar]
  • 13.Kroese FG, Wubbena AS, Seijen HG, Nieuwenhuis P. Germinal centers develop oligoclonally. Eur J Immunol. 1987;17:1069–1072. doi: 10.1002/eji.1830170726. [DOI] [PubMed] [Google Scholar]
  • 14.Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol. 1991;21:2951–2962. doi: 10.1002/eji.1830211209. [DOI] [PubMed] [Google Scholar]
  • 15.Kuppers R, Zhao M, Hansmann ML, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. Embo J. 1993;12:4955–4967. doi: 10.1002/j.1460-2075.1993.tb06189.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jacob J, Przylepa J, Miller C, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J Exp Med. 1993;178:1293–1307. doi: 10.1084/jem.178.4.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dal Porto JM, Haberman AM, Shlomchik MJ, Kelsoe G. Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers. Journal of immunology. 1998;161:5373–5381. [PubMed] [Google Scholar]
  • 18.Dal Porto JM, Haberman AM, Kelsoe G, Shlomchik MJ. Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. J Exp Med. 2002;195:1215–1221. doi: 10.1084/jem.20011550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shih TA, Meffre E, Roederer M, Nussenzweig MC. Role of BCR affinity in T cell dependent antibody responses in vivo. Nat Immunol. 2002;3:570–575. doi: 10.1038/ni803. [DOI] [PubMed] [Google Scholar]
  • 20.Schwickert TA, Victora GD, Fooksman DR, Kamphorst AO, Mugnier MR, Gitlin AD, Dustin ML, Nussenzweig MC. A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. The Journal of experimental medicine. 2011;208:1243–1252. doi: 10.1084/jem.20102477. This study shows that entry of B cells into GCs is limited by competition for T cells at the follicle border in the first few days after immunization.
  • 21.Gatto D, Paus D, Basten A, Mackay CR, Brink R. Guidance of B Cells by the Orphan G Protein-Coupled Receptor EBI2 Shapes Humoral Immune Responses. Immunity. 2009 doi: 10.1016/j.immuni.2009.06.016. [DOI] [PubMed] [Google Scholar]
  • 22.Pereira JP, Kelly LM, Xu Y, Cyster JG. EBI2 mediates B cell segregation between the outer and centre follicle. Nature. 2009 doi: 10.1038/nature08226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Schwickert TA, Alabyev B, Manser T, Nussenzweig MC. Germinal center reutilization by newly activated B cells. J Exp Med. 2009;206:2907–2914. doi: 10.1084/jem.20091225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bergqvist P, Stensson A, Hazanov L, Holmberg A, Mattsson J, Mehr R, Bemark M, Lycke NY. Re-utilization of germinal centers in multiple Peyer’s patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses. Mucosal immunology. 2013;6:122–135. doi: 10.1038/mi.2012.56. [DOI] [PubMed] [Google Scholar]
  • 25.Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC. Identification of human germinal center light and dark zone cells and their relationship to human B cell lymphomas. Blood. 2012 doi: 10.1182/blood-2012-03-415380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26*.Bannard O, Horton RM, Allen CD, An J, Nagasawa T, Cyster JG. Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection. Immunity. 2013;39:912–924. doi: 10.1016/j.immuni.2013.08.038. This study describes a B cell-intrinsic “clock” that controls the ability of GC B cells to switch between dark zone and light zone phenotypes.
  • 27**.Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004;5:943–952. doi: 10.1038/ni1100. This study identifies CXCL12/CXCR4 as the chemokine/receptor pair responsible for segregating the germinal center into dark and light zones.
  • 28.Kepler TB, Perelson AS. Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation. Immunol Today. 1993;14:412–415. doi: 10.1016/0167-5699(93)90145-B. [DOI] [PubMed] [Google Scholar]
  • 29.Oprea M, Perelson AS. Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. J Immunol. 1997;158:5155–5162. [PubMed] [Google Scholar]
  • 30.Radmacher MD, Kelsoe G, Kepler TB. Predicted and inferred waiting times for key mutations in the germinal centre reaction: evidence for stochasticity in selection. Immunology and cell biology. 1998;76:373–381. doi: 10.1046/j.1440-1711.1998.00753.x. [DOI] [PubMed] [Google Scholar]
  • 31.Meyer-Hermann ME, Maini PK, Iber D. An analysis of B cell selection mechanisms in germinal centers. Math Med Biol. 2006;23:255–277. doi: 10.1093/imammb/dql012. [DOI] [PubMed] [Google Scholar]
  • 32*.Khalil AM, Cambier JC, Shlomchik MJ. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science. 2012;336:1178–1181. doi: 10.1126/science.1213368. This study shows that proximal signaling downstream of the B cell receptor is surprisingly absent from germinal center B cells.
  • 33.Espeli M, Clatworthy MR, Bokers S, Lawlor KE, Cutler AJ, Kontgen F, Lyons PA, Smith KG. Analysis of a wild mouse promoter variant reveals a novel role for FcgammaRIIb in the control of the germinal center and autoimmunity. The Journal of experimental medicine. 2012;209:2307–2319. doi: 10.1084/jem.20121752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Talay O, Yan D, Brightbill HD, Straney EE, Zhou M, Ladi E, Lee WP, Egen JG, Austin CD, Xu M, et al. IgE(+) memory B cells and plasma cells generated through a germinal-center pathway. Nature immunology. 2012;13:396–404. doi: 10.1038/ni.2256. [DOI] [PubMed] [Google Scholar]
  • 35.Yang Z, Sullivan BM, Allen CD. Fluorescent in vivo detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition. Immunity. 2012;36:857–872. doi: 10.1016/j.immuni.2012.02.009. [DOI] [PubMed] [Google Scholar]
  • 36.He JS, Meyer-Hermann M, Xiangying D, Zuan LY, Jones LA, Ramakrishna L, de Vries VC, Dolpady J, Aina H, Joseph S, et al. The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response. The Journal of experimental medicine. 2013;210:2755–2771. doi: 10.1084/jem.20131539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Han S, Zheng B, Dal Porto J, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med. 1995;182:1635–1644. doi: 10.1084/jem.182.6.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Pulendran B, Kannourakis G, Nouri S, Smith KG, Nossal GJ. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature. 1995;375:331–334. doi: 10.1038/375331a0. [DOI] [PubMed] [Google Scholar]
  • 39.Shokat KM, Goodnow CC. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature. 1995;375:334–338. doi: 10.1038/375334a0. [DOI] [PubMed] [Google Scholar]
  • 40.Chan TD, Wood K, Hermes JR, Butt D, Jolly CJ, Basten A, Brink R. Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity. 2012;37:893–904. doi: 10.1016/j.immuni.2012.07.017. [DOI] [PubMed] [Google Scholar]
  • 41.Meyer-Hermann M, Mohr E, Pelletier N, Zhang Y, Victora GD, Toellner KM. A theory of germinal center B cell selection, division, and exit. Cell reports. 2012;2:162–174. doi: 10.1016/j.celrep.2012.05.010. [DOI] [PubMed] [Google Scholar]
  • 42.Eisen HN, Siskind GW. Variations in Affinities of Antibodies During the Immune Response. Biochemistry. 1964;3:996–1008. doi: 10.1021/bi00895a027. [DOI] [PubMed] [Google Scholar]
  • 43.Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, Ott RG, Anthony RM, Zebroski H, Hurley A, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature. 2009;458:636–640. doi: 10.1038/nature07930. [DOI] [PubMed] [Google Scholar]
  • 44.Crotty S. Follicular helper CD4 T cells (TFH) Annu Rev Immunol. 2011;29:621–663. doi: 10.1146/annurev-immunol-031210-101400. [DOI] [PubMed] [Google Scholar]
  • 45.Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 1998;281:96–99. doi: 10.1126/science.281.5373.96. [DOI] [PubMed] [Google Scholar]
  • 46.Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, Hartley SB, O’Garra A, Cahalan MD, Cyster JG. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 2005;3:e150. doi: 10.1371/journal.pbio.0030150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kerfoot SM, Yaari G, Patel JR, Johnson KL, Gonzalez DG, Kleinstein SH, Haberman AM. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity. 2011;34:947–960. doi: 10.1016/j.immuni.2011.03.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48*.Shulman Z, Gitlin AD, Targ S, Jankovic M, Pasqual G, Nussenzweig MC, Victora GD. T follicular helper cell dynamics in germinal centers. Science. 2013;341:673–677. doi: 10.1126/science.1241680. This study shows that Tfh cells can migrate between different germinal centers in the same lymph node.
  • 49.Haynes NM, Allen CD, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol. 2007;179:5099–5108. doi: 10.4049/jimmunol.179.8.5099. [DOI] [PubMed] [Google Scholar]
  • 50.Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature. 2008;455:764–769. doi: 10.1038/nature07345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kitano M, Moriyama S, Ando Y, Hikida M, Mori Y, Kurosaki T, Okada T. Bcl6 Protein Expression Shapes Pre-Germinal Center B Cell Dynamics and Follicular Helper T Cell Heterogeneity. Immunity. 2011 doi: 10.1016/j.immuni.2011.03.025. [DOI] [PubMed] [Google Scholar]
  • 52.Xu H, Li X, Liu D, Li J, Zhang X, Chen X, Hou S, Peng L, Xu C, Liu W, et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 2013;496:523–527. doi: 10.1038/nature12058. [DOI] [PubMed] [Google Scholar]
  • 53.Arnold CN, Campbell DJ, Lipp M, Butcher EC. The germinal center response is impaired in the absence of T cell-expressed CXCR5. Eur J Immunol. 2007;37:100–109. doi: 10.1002/eji.200636486. [DOI] [PubMed] [Google Scholar]
  • 54.Zheng B, Han S, Kelsoe G. T helper cells in murine germinal centers are antigen-specific emigrants that downregulate Thy-1. The Journal of experimental medicine. 1996;184:1083–1091. doi: 10.1084/jem.184.3.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Roers A, Hansmann ML, Rajewsky K, Kuppers R. Single-cell PCR analysis of T helper cells in human lymph node germinal centers. The American journal of pathology. 2000;156:1067–1071. doi: 10.1016/S0002-9440(10)64974-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Golby SJ, Dunn-Walters DK, Spencer J. Human tonsillar germinal center T cells are a diverse and widely disseminated population. European journal of immunology. 1999;29:3729–3736. doi: 10.1002/(SICI)1521-4141(199911)29:11<3729::AID-IMMU3729>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  • 57.Plotkin SA. Correlates of protection induced by vaccination. Clinical and vaccine immunology: CVI. 2010;17:1055–1065. doi: 10.1128/CVI.00131-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath MJ, Nussenzweig MC, Pulendran B, et al. A Blueprint for HIV Vaccine Discovery. Cell host & microbe. 2012;12:396–407. doi: 10.1016/j.chom.2012.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Krammer F, Palese P. Universal influenza virus vaccines: need for clinical trials. Nature immunology. 2013;15:3–5. doi: 10.1038/ni.2761. [DOI] [PubMed] [Google Scholar]
  • 60**.Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, Fire AZ, Roskin KM, Schramm CA, Zhang Z, et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature. 2013;496:469–476. doi: 10.1038/nature12053. This study describes the evolution the antibody response in an HIV-infected patient from initial infection to the development of broadly-neutralizing antibodies.
  • 61.Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TY, Pietzsch J, Fenyo D, Abadir A, Velinzon K, et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science. 2011;333:1633–1637. doi: 10.1126/science.1207227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC. Antibodies in HIV-1 vaccine development and therapy. Science. 2013;341:1199–1204. doi: 10.1126/science.1241144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Klein F, Diskin R, Scheid JF, Gaebler C, Mouquet H, Georgiev IS, Pancera M, Zhou T, Incesu RB, Fu BZ, et al. Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell. 2013;153:126–138. doi: 10.1016/j.cell.2013.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Jiang N, He J, Weinstein JA, Penland L, Sasaki S, He XS, Dekker CL, Zheng NY, Huang M, Sullivan M, et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Science translational medicine. 2013;5:171ra119. doi: 10.1126/scitranslmed.3004794. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES